标题
A review of phenformin, metformin, and imeglimin
作者
关键词
-
出版物
DRUG DEVELOPMENT RESEARCH
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-01-09
DOI
10.1002/ddr.21636
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Emerging Trends in Metformin Prescribing in the United States from 2000 to 2015
- (2019) Samantha Le et al. CLINICAL DRUG INVESTIGATION
- Metformin
- (2018) Julie Rodriguez et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030
- (2018) Christian Bommer et al. DIABETES CARE
- “What's in a structure?” The story of biguanides
- (2018) Deepika Kathuria et al. JOURNAL OF MOLECULAR STRUCTURE
- Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo
- (2018) Anila K. Madiraju et al. NATURE MEDICINE
- Metformin Inhibits Mouse Islet Insulin Secretion and Alters Intracellular Calcium in a Concentration-Dependent and Duration-Dependent Manner near the Circulating Range
- (2018) Lindor Gelin et al. Journal of Diabetes Research
- Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase
- (2018) Roger W. Hunter et al. NATURE MEDICINE
- Metformin: Focus on Melanoma
- (2018) Emilie Jaune et al. Frontiers in Endocrinology
- Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity
- (2018) Zydrune Polianskyte-Prause et al. FASEB JOURNAL
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- (2017) Hao Wu et al. NATURE MEDICINE
- Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data
- (2017) L. Nesti et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies
- (2017) Charalampos Mamoulakis et al. PHARMACOLOGY & THERAPEUTICS
- Imeglimin lowers glucose primarily by amplifying glucose-stimulated insulin secretion in high-fat-fed rodents
- (2016) Rachel J. Perry et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Blockade of P-Glycoprotein Decreased the Disposition of Phenformin and Increased Plasma Lactate Level
- (2016) Min-Koo Choi et al. Biomolecules & Therapeutics
- Extreme Basicity of Biguanide Drugs in Aqueous Solutions: Ion Transfer Voltammetry and DFT Calculations
- (2016) Jan Langmaier et al. JOURNAL OF PHYSICAL CHEMISTRY A
- Metformin: myths, misunderstandings and lessons from history
- (2016) Gillian Shenfield Australian Prescriber
- Guanidines from ‘toxic substances’ to compounds with multiple biological applications – Detailed outlook on synthetic procedures employed for the synthesis of guanidines
- (2015) Shaista Tahir et al. BIOORGANIC CHEMISTRY
- Imeglimin increases glucose-dependent insulin secretion and improves β-cell function in patients with type 2 diabetes
- (2015) G. Pacini et al. DIABETES OBESITY & METABOLISM
- Imeglimin: A Potential New Multi-Target Drug for Type 2 Diabetes
- (2015) Valerie Vuylsteke et al. Drugs in research & development
- Imeglimin Normalizes Glucose Tolerance and Insulin Sensitivity and Improves Mitochondrial Function in Liver of a High-Fat, High-Sucrose Diet Mice Model
- (2015) Guillaume Vial et al. DIABETES
- Two weeks of metformin treatment induces AMPK-dependent enhancement of insulin-stimulated glucose uptake in mouse soleus muscle
- (2014) Jonas Møller Kristensen et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy
- (2014) Pascale Fouqueray et al. DIABETES CARE
- Low Concentrations of Metformin Suppress Glucose Production in Hepatocytes through AMP-activated Protein Kinase (AMPK)
- (2014) Jia Cao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus
- (2014) Antonella Napolitano et al. PLoS One
- Insulin Receptor Signaling in Normal and Insulin-Resistant States
- (2014) J. Boucher et al. Cold Spring Harbor Perspectives in Biology
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
- (2013) Russell A. Miller et al. NATURE
- Repositioning metformin for cancer prevention and treatment
- (2013) Brendan J. Quinn et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Metformin: an old but still the best treatment for type 2 diabetes
- (2013) Lilian Beatriz Aguayo Rojas et al. Diabetology & Metabolic Syndrome
- Phenformin as prophylaxis and therapy in breast cancer xenografts
- (2012) M V C L Appleyard et al. BRITISH JOURNAL OF CANCER
- The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
- (2012) P. Fouqueray et al. DIABETES CARE
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Imeglimin, a novel glimin oral antidiabetic, exhibits a good efficacy and safety profile in type 2 diabetic patients
- (2012) V. Pirags et al. DIABETES OBESITY & METABOLISM
- Metformin pathways
- (2012) Li Gong et al. Pharmacogenetics and Genomics
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
- (2011) K. J. Lipska et al. DIABETES CARE
- The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
- (2011) Mette M.H. Christensen et al. Pharmacogenetics and Genomics
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- Resolution of (±)-Imeglimin-2,4-dichlorophenylacetate Methanol Solvate by Preferential Crystallization
- (2010) Saoussen Wacharine-Antar et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Biological activities of guanidine compounds
- (2009) Franciszek Saczewski et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Involvement of Human Multidrug and Toxin Extrusion 1 in the Drug Interaction between Cimetidine and Metformin in Renal Epithelial Cells
- (2009) M. Tsuda et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Mechanisms of Action of Metformin in Type 2 Diabetes and Associated Complications: An Overview
- (2008) Sonia Correia et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation